NDA 50203, held by Parke Davis. Chloramphenicol; Polymyxin B Sulfate.
As of Nov 13, 2026, NDA 50203 (Chloromyxin), held by Parke Davis, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Chloromyxin1%;10,000 UNITS/GM ยท ointment;ophthalmic | Chloramphenicol; Polymyxin B Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
